|
<
Back
December 2000, Vol. 2
Cross-functional team focus on marketing is key to project success
December 2000, Vol. 2
Cross-functional team focus on marketing is key to project success
October 2000, Vol. 2
User fees credited with 51% drop in average approval times since 1993
September 2000
Editorial: Don't turn back the clock on drug regulatory reform
July/August 2000, Vol. 2
Maine enacts drug price controls; 16 other states taking similar action
June 2000, Vol. 2
Pharmaceutical industry innovation is more dispersed despite M&A activity
May 2000, Vol. 2
Influence of pharmacoeconomics in drug R&D decisions is growing
April 2000, Vol. 2
Drug firms embrace pediatric study program during first 2 years of FDAMA
March 2000, Vol. 2
European approval of new biotech drugs outpaces US approval
January 2000, Vol. 2
Effective data use drives portfolio management and global strategies
|